-
New Roadmap for Parkinson’s Preclinical Trials Proposed
A new roadmap for preclinical and clinical trials investigating compounds to treat and prevent Parkinson’s disease was proposed by a team of international academic and industry researchers, the Alpha-Synuclein Clinical Path Working Group, in conjunction with the Michael J. Fox Foundation for Parkinson’s Research.
Click here to read more about it.
What do you think about this news?
Sorry, there were no replies found.
Log in to reply.